Literature DB >> 24532414

Effects of L-arginine, mirabegron, and oxybutynin on the primary bladder afferent nerve activities synchronized with reflexic, rhythmic bladder contractions in the rat.

Naoki Aizawa1, Yukio Homma, Yasuhiko Igawa.   

Abstract

AIMS: We measured single-unit mechanosensitive afferent activities (SAAs) during reflexic, rhythmic bladder contractions (RBCs), and examined whether L-arginine, an NO substrate, and mirabegron, a β3-adrenoceptor agonist, and oxybutynin, an antimuscarinic agent, can affect the SAAs in such condition.
METHODS: Twenty-nine female Sprague-Dawley rats were anesthetized. SAA was identified by electro-stimulation of the left pelvic nerve and by bladder distension, and was divided into Aδ- or C-fibers by conduction velocity. To produce the RBCs, right L6 dorsal roots were kept intact. Under an isovolumetric condition, vehicle and L-arginine (300 mg/kg) or mirabegron (1 mg/kg) or oxybutynin (1 mg/kg) were administered intravenously.
RESULTS: All of the Aδ- (n = 26) and C-fibers (n = 29) capable of responding to bladder distention were also responsive to bladder contractions during RBCs. The amplitude and duration of RBCs significantly decreased after mirabegron- and oxybutynin-administrations, but not after L-arginine-administration. The interval of RBC was significantly elongated after L-arginine- and mirabegron-administrations. Regarding the SAAs, the peaks of firing rate (FR) during RBCs and FR during the non-contractile phase were decreased after L-arginine-administration, which were more remarkable for Aδ-fibers than C-fibers. Similar results were observed after mirabegron-administration only for Aδ-fibers. After oxybutynin-administration, the peak of FR of both fiber-SAAs significantly decreased, but the change was not significant when the value was normalized by the amplitude of RBCs.
CONCLUSIONS: The present results indicate that mechanosensitive Aδ- and C-fibers were also responsive to bladder contractions, and that NO production and β3-adrenoceptor stimulation can inhibit SAAs mainly of Aδ-fibers synchronized with RBCs.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  Sprague-Dawley rats; afferent; nitric oxide; urinary bladder; β3-adrenoceptor

Mesh:

Substances:

Year:  2014        PMID: 24532414     DOI: 10.1002/nau.22571

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  6 in total

Review 1.  β3 -Adrenoceptors in the normal and diseased urinary bladder-What are the open questions?

Authors:  Yasuhiko Igawa; Naoki Aizawa; Martin C Michel
Journal:  Br J Pharmacol       Date:  2019-05-03       Impact factor: 8.739

2.  Effects of nicotinic receptor agonists on bladder afferent nerve activity in an in vitro bladder-pelvic nerve preparation.

Authors:  Yongbei Yu; Stephanie L Daugherty; William C de Groat
Journal:  Brain Res       Date:  2016-02-11       Impact factor: 3.252

3.  β3 Adrenoceptor-induced cholinergic inhibition in human and rat urinary bladders involves the exchange protein directly activated by cyclic AMP 1 favoring adenosine release.

Authors:  Isabel Silva; M Teresa Magalhães-Cardoso; Fátima Ferreirinha; Sílvia Moreira; Ana Filipa Costa; Diogo Silva; Cátia Vieira; Miguel Silva-Ramos; Paulo Correia-de-Sá
Journal:  Br J Pharmacol       Date:  2020-02-06       Impact factor: 8.739

Review 4.  The effect of amino acids on the bladder cycle: a concise review.

Authors:  Özer Ural Çakıcı; Sibel Dinçer
Journal:  Amino Acids       Date:  2021-12-01       Impact factor: 3.520

5.  Fiber type-specific afferent nerve activity induced by transient contractions of rat bladder smooth muscle in pathological states.

Authors:  Nahoko Kuga; Asao Tanioka; Koichiro Hagihara; Tomoyuki Kawai
Journal:  PLoS One       Date:  2017-12-21       Impact factor: 3.240

6.  Effects of combined treatment with fesoterodine and mirabegron in a pelvic congestion rat model: Results from in vitro and in vivo functional studies.

Authors:  Kimio Sugaya; Hidetomi Yamagami; Saori Nishijima; Katsumi Kadekawa; Masanori Hizue; Yoshihiko Ito; Shizuo Yamada
Journal:  Low Urin Tract Symptoms       Date:  2019-11-22       Impact factor: 1.592

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.